Seroma at the Donor Site of the TRAM Flap, With or Without Quilting Suture: A Comparative Study Using Ultrasound (STRAMQUSG)

May 25, 2011 updated by: Federal University of São Paulo

Seroma at the Donor Site of the TRAM Flap, With or Without Quilting Suture.

Patient undergoing breast reconstruction with lower abdominal flap, benefit when points are used for membership (between the aponeurosis of the abdominal flap and underlying muscles) for closing the donor area, where there is reduced incidence of complications.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study evaluated seroma formation at the donor site of the TRAM patients who underwent breast reconstruction. Forty-eight breast reconstructions were performed using the bipedicled TRAM flap. The patients were randomly allocated into three groups of 16 participants each: DN group, use of suction drains but no quilting sutures between the remaining abdominal flap and musculoaponeurotic layer of the anterior abdominal wall; QS+DN group, use of quilting sutures and suction drains; and QS group, use of quilting sutures but no suction drains. In order to determine seroma formation, ultrasound examinations were performed on postoperative days 7 and 14 in 5 regions of the abdominal wall: epigastric, umbilical, hypogastric, right iliac, and left iliac regions.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Phase 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • were age between 20 and 65 years
  • body mass index (BMI) ≤ 30 kg/m2
  • non-smokers.

Exclusion criteria:

  • no skin excess in the infraumbilical region
  • previous abdominoplasty
  • uncontrolled systemic disease
  • such as diabetes mellitus and arterial hypertension
  • collagen diseases
  • psychiatric disorders
  • large weight loss
  • and/or postoperative abdominal scars that could hinder flap vascularization.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: no quilting sutures but drains
  • quilting sutures and drains
  • quilting sutures but no drains
Other Names:
  • points
EXPERIMENTAL: quilting sutures and drains
  • quilting sutures and drains
  • quilting sutures but no drains
Other Names:
  • points
EXPERIMENTAL: quilting sutures but no drains
  • quilting sutures and drains
  • quilting sutures but no drains
Other Names:
  • points

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reducing seroma in donor site of the TRAM flap
Time Frame: 15 days
Seroma formation was identified clinically and confirmed by ultrasound examination. Clinical examination consisted of evaluation of early symptoms (bulging and distension of the skin, signs of fluid accumulation), palpation, and percussion. Ultrasound examination was performed on postoperative days 7 and 14 to detect the presence of seroma at the TRAM flap donor site. The patients were placed in the supine position during the examination. Upon detection of seroma, ultrasound-guided puncture was performed, and the number of punctures and volume of seroma aspirated were recorded.
15 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: luis Rossetto, MD, Graduate Program in Plastic Surgery, School of Medicine, Universidade Federal de São PaConception and design of the study, drafting the article, revising it critically for important intellectual content, and final approval of the version to be submitted.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2009

Primary Completion (ACTUAL)

October 1, 2010

Study Completion (ACTUAL)

October 1, 2010

Study Registration Dates

First Submitted

May 16, 2011

First Submitted That Met QC Criteria

May 20, 2011

First Posted (ESTIMATE)

May 24, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

May 26, 2011

Last Update Submitted That Met QC Criteria

May 25, 2011

Last Verified

June 1, 2009

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CEP 1995 08
  • CEP 1995/08 (OTHER: Comisão de Ética Médica do Hospital São Paulo)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Seroma

Clinical Trials on quilting suture

Subscribe